Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adipic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.74 |
| ▸ | PPARG | P37231 | 7/20 | 0.74 |
| ▸ | PPARD | Q03181 | 7/20 | 0.74 |
| ▸ | PPARA | Q07869 | 7/20 | 0.74 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.74 |
| ▸ | TSHR | P16473 | 4/20 | 0.74 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | FABP4 | P15090 | 3/20 | 0.74 |
| ▸ | TLR2 | O60603 | 2/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.74 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | ESR1 | P03372 | 1/20 | 0.74 |
| ▸ | PDE4A | P27815 | 1/20 | 0.74 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL538428 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5808089 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL13571698 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL4815941 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL20725794 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL23831109 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| Adipic Acid SCHEMBL5664346 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL2471966 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL16319776 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL9261120 | 1.00 | GPR84 (0.74) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225987-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2023-07-20 | — | — | US | claimed |
| EP-4171529-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2023-05-03 | — | — | EP | claimed |
| WO-2021262917-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Dermavant Sciences GmbH (CH) | 2021-12-30 | — | — | WO | claimed |
| EP-3166574-B1 | COSMETIC COMPOSITION BASED ON COLOR PARTICLES, STEARALKONIUM HECTORITE, POLYHYDROXYSTEARIC ACID, POLYGLYCERYL-1-PENTAISOSTEARATE AND A POLAR ACTIVATOR | MARY KAY INC (US) | 2021-03-31 | — | — | EP | claimed |
| CN-105686973-B | Makeup removing emulsion and wet tissue | 金红叶纸业集团有限公司 | 2020-10-23 | — | — | CN | claimed |
| US-9862853-B2 | Dispersion, gel and emulsification system | CRODA SINGAPORE PTE LIMITED (SG) | 2018-01-09 | — | — | US | claimed |
| EP-3166574-A1 | COSMETIC COMPOSITIONS | Mary Kay, Inc. (US) | 2017-05-17 | — | — | EP | claimed |
| WO-2016007519-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2016-01-14 | — | — | WO | claimed |
| US-20160008263-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. | 2016-01-14 | — | — | US | claimed |
| US-20150320041-A1 | NON-AEROSOL FOAMING ALCOHOL HAND SANITIZER | S. C. JOHNSON & SON, INC. | 2015-11-12 | — | — | US | claimed |
| US-20130090380-A1 | NON-AEROSOL FOAMING ALCOHOL HAND SANITIZER | AMERICAN STERILIZER COMPANY (US) | 2013-04-11 | — | — | US | claimed |
| US-20100150850-A1 | DISPERSION, GEL AND EMULSIFICATION SYSTEM | CRODA SINGAPORE PTE LIMITED (SG) | 2010-06-17 | — | — | US | claimed |
| US-7416719-B2 | Containing a lauryl glucoside emulsifier imparts to impart an enhanced soft, silky feel; spreads uniformly; forms a stable oil-in-water emulsion | PLAYTEX PRODUCTS, INC. (US) | 2008-08-26 | — | — | US | claimed |
| US-7091243-B2 | Anti-irritants | CRODA, INC. (US) | 2006-08-15 | — | — | US | claimed |
| EP-1414397-A4 | ANTI-IRRITANTS | CRODA INC (US) | 2006-07-19 | — | — | EP | claimed |
| US-20040247543-A1 | Sunscreen compositions | PLAYTEX PRODUCTS, INC. | 2004-12-09 | — | — | US | claimed |
| US-20040185018-A1 | Nail enamelcompositions and methods | CITICORP USA, INC. | 2004-09-23 | — | — | US | claimed |
| EP-1414397-A2 | ANTI-IRRITANTS | Croda, Inc. (US) | 2004-05-06 | — | — | EP | claimed |
| US-20030114520-A1 | Anti-irritants | CRODA, INC. | 2003-06-19 | — | — | US | claimed |
| WO-2003013439-A2 | ANTI-IRRITANTS | CRODA, INC. (US) | 2003-02-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040185018-A1 | Nail enamelcompositions and methods | ETF1, POLR1C, PIK3C3 | GPR84 3967/4885PPARG 408/4885PPARD 686/4885 |
| US-20230225987-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | TSLP, SQLE, DHCR7 | GPR84 2532/4885PPARG 812/4885PPARD 598/4885 |
| US-20030114520-A1 | Anti-irritants | HAO2, DDO, SLC16A7 | GPR84 896/4885PPARG 553/4885PPARD 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.